Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Eisenbach L

Collect these papers and discover other ones on Labmeeting. Learn more.

The human 1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene.

+ cite this

+ View Abstract

Daniel-Carmi V, Makovitzki-Avraham E, Reuven EM, Goldstein I, Zilkha N, Rotter V, Tzehoval E, and Eisenbach L

International journal of cancer. Journal international du cancer 125(12):2810-9, 2009 Dec 15 - Who cited this? | PubMed ID: 19544527 | Fulltext

T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis.

+ cite this

+ View Abstract

Volovitz I, Mor F, Machlenkin A, Goldberger O, Marmor Y, Eisenbach L, and Cohen I

Immunology 128(1):92-102, 2009 Sep - Who cited this? | PubMed ID: 19689739 | Fulltext

A systems immunology approach to the host-tumor interaction: large-scale patterns of natural autoantibodies distinguish healthy and tumor-bearing mice.

+ cite this

+ View Abstract

Merbl Y, Itzchak R, Vider-Shalit T, Louzoun Y, Quintana FJ, Vadai E, Eisenbach L, and Cohen IR

PLoS ONE 4(6):e6053, 2009 - Who cited this? | PubMed ID: 19557135 | Fulltext

Exuberated numbers of tumor-specific T cells result in tumor escape.

+ cite this

+ View Abstract

Goldberger O, Volovitz I, Machlenkin A, Vadai E, Tzehoval E, and Eisenbach L

Cancer research 68(9):3450, 2008 May 1 - Who cited this? | PubMed ID: 18451173 | Fulltext

Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs.

+ cite this

+ View Abstract

Machlenkin A, Uzana R, Frankenburg S, Eisenberg G, Eisenbach L, Pitcovski J, Gorodetsky R, Nissan A, Peretz T, and Lotem M

Cancer research 68(6):2006, 2008 Mar 15 - Who cited this? | PubMed ID: 18339883 | Fulltext

Pneumococcal capsular polysaccharide is immunogenic when present on the surface of macrophages and dendritic cells: TLR4 signaling induced by a conjugate vaccine or by lipopolysaccharide is conducive.

+ cite this

+ View Abstract

Cohen N, Stolarsky-Bennun M, Amir-Kroll H, Margalit R, Nussbaum G, Cohen-Sfady M, Pevsner-Fischer M, Fridkin M, Bercovier H, Eisenbach L, Jung S, and Cohen IR

Journal of immunology (Baltimore, Md. : 1950) 180(4):2409, 2008 Feb 15 - Who cited this? | PubMed ID: 18250450 | Fulltext

Trogocytosis of MHC-I/Peptide Complexes Derived from Tumors and Infected Cells Enhances Dendritic Cell Cross-Priming and Promotes Adaptive T Cell Responses.

+ cite this

+ View Abstract

Zhang QJ, Li XL, Wang D, Huang XC, Mathis JM, Duan WM, Knight D, Shi R, Glass J, Zhang DQ, Eisenbach L, and Jefferies WA

PLoS ONE 3(8), 2008 - Who cited this? | PubMed ID: 18769733 | Fulltext

'1-8 interferon inducible gene family': putative colon carcinoma-associated antigens.

+ cite this

+ View Abstract

Tirosh B, Daniel-Carmi V, Carmon L, Paz A, Lugassy G, Vadai E, Machlenkin A, Bar-Haim E, Do MS, Ahn IS, Fridkin M, Tzehoval E, and Eisenbach L

British journal of cancer 97(12):1655, 2007 Dec 17 - Who cited this? | PubMed ID: 18071348 | Fulltext

Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth.

+ cite this

+ View Abstract

Issaeva I, Zonis Y, Rozovskaia T, Orlovsky K, Croce CM, Nakamura T, Mazo A, Eisenbach L, and Canaani E

Molecular and cellular biology 27(5):1889, 2007 Mar - Who cited this? | PubMed ID: 17178841 | Fulltext

Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice.

+ cite this

+ View Abstract

Machlenkin A, Azriel-Rosenfeld R, Volovitz I, Vadai E, Lev A, Paz A, Goldberger O, Reiter Y, Tzehoval E, Benhar I, and Eisenbach L

Cancer immunology, immunotherapy : CII 56(2):217, 2007 Feb - Who cited this? | PubMed ID: 16738849 | Fulltext

O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.

+ cite this

+ View Abstract

Stepensky D, Tzehoval E, Vadai E, and Eisenbach L

Clinical and experimental immunology 143(1):139, 2006 Jan - Who cited this? | PubMed ID: 16367945 | Fulltext

Induction of antitumor immunity by CTL epitopes genetically linked to membrane-anchored beta2-microglobulin.

+ cite this

+ View Abstract

Margalit A, Sheikhet HM, Carmi Y, Berko D, Tzehoval E, Eisenbach L, and Gross G

Journal of immunology (Baltimore, Md. : 1950) 176(1):217, 2006 Jan 1 - Who cited this? | PubMed ID: 16365413 | Fulltext

Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy.

+ cite this

+ View Abstract

Machlenkin A, Paz A, Bar Haim E, Goldberger O, Finkel E, Tirosh B, Volovitz I, Vadai E, Lugassy G, Cytron S, Lemonnier F, Tzehoval E, and Eisenbach L

Cancer research 65(14):6435, 2005 Jul 15 - Who cited this? | PubMed ID: 16024648 | Fulltext

Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.

+ cite this

+ View Abstract

Machlenkin A, Goldberger O, Tirosh B, Paz A, Volovitz I, Bar-Haim E, Lee SH, Vadai E, Tzehoval E, and Eisenbach L

Clinical cancer research : an official journal of the American Association for Cancer Research 11(13):4955, 2005 Jul 1 - Who cited this? | PubMed ID: 16000595 | Fulltext

Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules.

+ cite this

+ View Abstract

Berko D, Carmi Y, Cafri G, Ben-Zaken S, Sheikhet HM, Tzehoval E, Eisenbach L, Margalit A, and Gross G

Journal of immunology (Baltimore, Md. : 1950) 174(4):2116, 2005 Feb 15 - Who cited this? | PubMed ID: 15699142 | Fulltext

MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides.

+ cite this

+ View Abstract

Bar-Haim E, Paz A, Machlenkin A, Hazzan D, Tirosh B, Carmon L, Brenner B, Vadai E, Mor O, Stein A, Lemonnier FA, Tzehoval E, and Eisenbach L

British journal of cancer 91(2):398, 2004 Jul 19 - Who cited this? | PubMed ID: 15213716 | Fulltext

Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8(+) T cell population in different tissues.

+ cite this

+ View Abstract

Qimron U, Paul L, Bar-Haim E, Bloushtain N, Eisenbach L, Staats HF, and Porgador A

Vaccine 22(11-12):1390, 2004 Mar 29 - Who cited this? | PubMed ID: 15063561 | Fulltext

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.

+ cite this

+ View Abstract

Lee SH, Bar-Haim E, Machlenkin A, Goldberger O, Volovitz I, Vadai E, Tzehoval E, and Eisenbach L

Cancer gene therapy 11(3):237, 2004 Mar - Who cited this? | PubMed ID: 14739939 | Fulltext

The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients.

+ cite this

+ View Abstract

Markel G, Mussaffi H, Ling KL, Salio M, Gadola S, Steuer G, Blau H, Achdout H, de Miguel M, Gonen-Gross T, Hanna J, Arnon TI, Qimron U, Volovitz I, Eisenbach L, Blumberg RS,

(show remaining authors)

Blood 103(5):1770, 2004 Mar 1 - Who cited this? | PubMed ID: 14604968 | Fulltext

Expression of FasL by tumor cells does not abrogate anti-tumor CTL function.

+ cite this

+ View Abstract

Lee SH, Bar-Haim E, Goldberger O, Reich-Zeliger S, Vadai E, Tzehoval E, and Eisenbach L

Immunology letters 91(2-3):119, 2004 Feb 15 - Who cited this? | PubMed ID: 15019279 | Fulltext

Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.

+ cite this

+ View Abstract

Denkberg G, Lev A, Eisenbach L, Benhar I, and Reiter Y

Journal of immunology (Baltimore, Md. : 1950) 171(5):2197, 2003 Sep 1 - Who cited this? | PubMed ID: 12928363 | Fulltext

Overexpression of a set of genes, including WISP-1, common to pulmonary metastases of both mouse D122 Lewis lung carcinoma and B16-F10.9 melanoma cell lines.

+ cite this

+ View Abstract

Margalit O, Eisenbach L, Amariglio N, Kaminski N, Harmelin A, Pfeffer R, Shohat M, Rechavi G, and Berger R

British journal of cancer 89(2):314, 2003 Jul 21 - Who cited this? | PubMed ID: 12865923 | Fulltext

A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in mice.

+ cite this

+ View Abstract

Papo N, Shahar M, Eisenbach L, and Shai Y

The Journal of biological chemistry 278(23):21018, 2003 Jun 6 - Who cited this? | PubMed ID: 12646578 | Fulltext

Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T.

+ cite this

+ View Abstract

Cohen CJ, Hoffmann N, Farago M, Hoogenboom HR, Eisenbach L, and Reiter Y

Cancer research 62(20):5835, 2002 Oct 15 - Who cited this? | PubMed ID: 12384546 | Fulltext

Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice.

+ cite this

+ View Abstract

Carmon L, Bobilev-Priel I, Brenner B, Bobilev D, Paz A, Bar-Haim E, Tirosh B, Klein T, Fridkin M, Lemonnier F, Tzehoval E, and Eisenbach L

The Journal of clinical investigation 110(4):453, 2002 Aug - Who cited this? | PubMed ID: 12189239 | Fulltext

CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.

+ cite this

+ View Abstract

Markel G, Lieberman N, Katz G, Arnon TI, Lotem M, Drize O, Blumberg RS, Bar-Haim E, Mader R, Eisenbach L, and Mandelboim O

Journal of immunology (Baltimore, Md. : 1950) 168(6):2803, 2002 Mar 15 - Who cited this? | PubMed ID: 11884449 | Fulltext

Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens.

+ cite this

+ View Abstract

Barnea E, Beer I, Patoka R, Ziv T, Kessler O, Tzehoval E, Eisenbach L, Zavazava N, and Admon A

European journal of immunology 32(1):213, 2002 Jan - Who cited this? | PubMed ID: 11782012 | Fulltext

Surrogate markers of antitumor responses: in vitro activation of T cells by autologous tumor peptides.

+ cite this

+ View Abstract

Zier K, Maddux JM, Johnson K, Sung M, Mandeli J, Eisenbach L, and Schwartz M

Clinical cancer research : an official journal of the American Association for Cancer Research 7(3 Suppl):818, 2001 Mar - Who cited this? | PubMed ID: 11300478 | Fulltext

Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing.

+ cite this

+ View Abstract

Tirosh B, Fridkin M, Tzehoval E, Vadai E, Lemonnier FA, and Eisenbach L

Journal of immunotherapy (Hagerstown, Md. : 1997) 23(6):622 - Who cited this? | PubMed ID: 11186150 | Fulltext

Antitumor vaccination using peptide based vaccines.

+ cite this

+ View Abstract

Eisenbach L, Bar-Haim E, and El-Shami K

Immunology letters 74(1):27, 2000 Sep 15 - Who cited this? | PubMed ID: 10996624 | Fulltext

Anti-tumor vaccination in heterozygous congenic F1 mice: presentation of tumor-associated antigen by the two parental class I alleles.

+ cite this

+ View Abstract

Carmon L, Tzehoval E, Tirosh B, el-Shami KM, Bar-Haim E, Vadai E, Feldman M, and Eisenbach L

Journal of immunotherapy (Hagerstown, Md. : 1997) 23(3):344 - Who cited this? | PubMed ID: 10838663 | Fulltext

IFNgamma secretion following stimulation with total tumor peptides from autologous human tumors.

+ cite this

+ View Abstract

Zier K, Johnson K, Maddux JM, Sung M, Mandeli J, Eisenbach L, and Schwartz M

Journal of immunological methods 241(1-2):61, 2000 Jul 31 - Who cited this? | PubMed ID: 10915849 | Fulltext

Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain.

+ cite this

+ View Abstract

Carmon L, el-Shami KM, Paz A, Pascolo S, Tzehoval E, Tirosh B, Koren R, Feldman M, Fridkin M, Lemonnier FA, and Eisenbach L

International journal of cancer. Journal international du cancer 85(3):391, 2000 Feb 1 - Who cited this? | PubMed ID: 10652432 | Fulltext

Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide.

+ cite this

+ View Abstract

el-Shami KM, Tirosh B, Popovic D, Carmon L, Tzehoval E, Vadai E, Feldman M, and Eisenbach L

International journal of cancer. Journal international du cancer 85(2):236, 2000 Jan 15 - Who cited this? | PubMed ID: 10629083 | Fulltext

Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines.

+ cite this

+ View Abstract

el-Shami KM, Tzehoval E, Vadai E, Feldman M, and Eisenbach L

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 19(12):1391, 1999 Dec - Who cited this? | PubMed ID: 10638708 | Fulltext

Immunogenicity of H-2Kb-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination.

+ cite this

+ View Abstract

Tirosh B, El-Shami K, Vaisman N, Carmon L, Bar-Haim E, Vadai E, Feldman M, Fridkin M, and Eisenbach L

Immunology letters 70(1):21, 1999 Oct 1 - Who cited this? | PubMed ID: 10541048 | Fulltext

MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope.

+ cite this

+ View Abstract

El-Shami K, Tirosh B, Bar-Haim E, Carmon L, Vadai E, Fridkin M, Feldman M, and Eisenbach L

European journal of immunology 29(10):3295, 1999 Oct - Who cited this? | PubMed ID: 10540341 | Fulltext

Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12.

+ cite this

+ View Abstract

Popovic D, el-Shami KM, Vadai E, Feldman M, Tzehoval E, and Eisenbach L

Clinical & experimental metastasis 16(7):623, 1998 Oct - Who cited this? | PubMed ID: 9932609 | Fulltext

Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas.

+ cite this

+ View Abstract

Mandelboim O, Bar-Haim E, Vadai E, Fridkin M, and Eisenbach L

Journal of immunology (Baltimore, Md. : 1950) 159(12):6030, 1997 Dec 15 - Who cited this? | PubMed ID: 9550401 | Fulltext

Correction. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma.

+ cite this

Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, and Eisenbach L

Nature 390(6660):643, 1997 Dec 11 - Who cited this? | PubMed ID: 9767009 | Fulltext

DAP kinase links the control of apoptosis to metastasis.

+ cite this

+ View Abstract

Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L, and Kimchi A

Nature 390(6656):180, 1997 Nov 13 - Who cited this? | PubMed ID: 9367156 | Fulltext

Modification of PDGFalpha receptor expression or function alters the metastatic phenotype of 3LL cells.

+ cite this

+ View Abstract

Fitzer-Attas CJ, Do MS, Feigelson S, Vadai E, Feldman M, and Eisenbach L

Oncogene 15(13):1545, 1997 Sep 25 - Who cited this? | PubMed ID: 9380406 | Fulltext

Unmasking by soluble IL-6 receptor of IL-6 effect on metastatic melanoma: growth inhibition and differentiation of B16-F10.9 tumor cells.

+ cite this

+ View Abstract

Oh JW, Katz A, Harroch S, Eisenbach L, Revel M, and Chebath J

Oncogene 15(5):569, 1997 Jul 31 - Who cited this? | PubMed ID: 9247310 | Fulltext

PACT: cloning and characterization of a cellular p53 binding protein that interacts with Rb.

+ cite this

+ View Abstract

Simons A, Melamed-Bessudo C, Wolkowicz R, Sperling J, Sperling R, Eisenbach L, and Rotter V

Oncogene 14(2):145, 1997 Jan 16 - Who cited this? | PubMed ID: 9010216 | Fulltext

Esterase inhibitors diminish the modulation of gene expression by butyric acid derivative, pivaloyloxymethyl butyrate (AN-9).

+ cite this

+ View Abstract

Rabizadeh E, Shaklai M, Eisenbach L, Nudelman A, and Rephaeli A

Israel journal of medical sciences 32(12):1186-91, 1996 Dec - Who cited this? | PubMed ID: 9007151 | Fulltext

Curing metastases? Gene and peptide therapy.

+ cite this

Eisenbach L

Current topics in microbiology and immunology 213 ( Pt 3):85-100, 1996 - Who cited this? | PubMed ID: 8815012 | Fulltext

Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.

+ cite this

+ View Abstract

Mandelboim O, Vadai E, Feldman M, and Eisenbach L

Gene therapy 2(10):757-65, 1995 Dec - Who cited this? | PubMed ID: 8750016 | Fulltext

Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.

+ cite this

+ View Abstract

Porgador A, Tzehoval E, Vadai E, Feldman M, and Eisenbach L

Cancer research 55(21):4941-9, 1995 Nov 1 - Who cited this? | PubMed ID: 7585534 | Fulltext

Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides.

+ cite this

+ View Abstract

Mandelboim O, Vadai E, Fridkin M, Katz-Hillel A, Feldman M, Berke G, and Eisenbach L

Nature medicine 1(11):1179-83, 1995 Nov - Who cited this? | PubMed ID: 7584991 | Fulltext

Interleukin-6: effects on tumor models in mice and on the cellular regulation of transcription factor IRF-1.

+ cite this

Revel M, Katz A, Eisenbach L, Feldman M, Haran-Ghera N, Harroch S, and Chebath J

Annals of the New York Academy of Sciences 762:342-55; discussion 355-6, 1995 Jul 21 - Who cited this? | PubMed ID: 7545371 | Fulltext

Search Google Scholar for Eisenbach L

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!